I agree that this site is using cookies. You can find further informations here.
X
Coons, Mary M.
~ 300  results:
Search for persons X
?
1

Harnessing type I CRISPR–Cas systems for genome engineering..:

Cameron, Peter ; Coons, Mary M. ; Klompe, Sanne E....
Nature Biotechnology.  37 (2019)  12 - p. 1471-1477 , 2019
Link: https://doi.org/10.1038/..
 
?
2

Structural Synergy and Molecular Crosstalk between Bacteria..:

Mott, Melissa L. ; Erzberger, Jan P. ; Coons, Mary M..
Cell.  135 (2008)  4 - p. 623-634 , 2008
Link: https://doi.org/10.1016/..
 
?
3

Division of Labor in Helicase Loading: Crosstalk Between Ba..:

Mott, Melissa L ; Erzberger, Jan P ; Coons, Mary M.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610854.  , 2008
Link: http://www.ncbi.nlm.nih...
 
?
4

Structural basis of Nav1.7 inhibition by an isoform-selecti..:

Ahuja, Shivani ; Mukund, Susmith ; Deng, Lunbin...
Science.  350 (2015)  6267 - p. 1491 ff. , 2015
Link: http://www.jstor.org/sta..
 
?
5

USP30 and parkin homeostatically regulate atypical ubiquiti..:

Cunningham, Christian N. ; Baughman, Joshua M. ; Phu, Lilian...
Nature Cell Biology.  17 (2015)  2 - p. 160-169 , 2015
Link: https://doi.org/10.1038/..
 
?
6

An expert panel Delphi consensus statement on the use of pa..:

Wilson, Melisa ; Anguiano, Rebekah H. ; Awdish, Rana L. A....
Pulmonary Circulation.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
7

Novel pathogenic variants and genes for myopathies identifi..:

Hunter, Jesse M. ; Ahearn, Mary Ellen ; Balak, Christopher D....
Molecular Genetics & Genomic Medicine.  3 (2015)  4 - p. 283-301 , 2015
Link: https://doi.org/10.1002/..
 
?
8

Developing a patient-centered outcome measure for complemen..:

Ritenbaugh, Cheryl ; Nichter, Mimi ; Nichter, Mark A...
BMC Complementary and Alternative Medicine.  11 (2011)  1 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
9

Novel pathogenic variants and genes for myopathies identifi..:

Hunter, Jesse M ; Ahearn, Mary Ellen ; Balak, Christopher D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521965/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
10

Developing a patient-centered outcome measure for complemen..:

Ritenbaugh Cheryl ; Nichter Mimi ; Nichter Mark A...
http://www.biomedcentral.com/1472-6882/11/135.  , 2011
Link: https://doi.org/10.1186/..
 
?
11

Developing a patient-centered outcome measure for complemen..:

Ritenbaugh, Cheryl ; Nichter, Mimi ; Nichter, Mark A...
http://www.biomedcentral.com/1472-6882/11/135.  , 2011
Link: http://www.biomedcentral..
 
?
12

An expert panel Delphi consensus statement on the use of pa..:

Melisa Wilson ; Rebekah H. Anguiano ; Rana L. A. Awdish...
https://doi.org/10.1002/pul2.12003.  , 2022
Link: https://doi.org/10.1002/..
 
?
13

Role and impact of a clinical pharmacist in an ambulatory r..:

Coons, Leslie M ; Loucks, Jennifer
American Journal of Health-System Pharmacy.  80 (2023)  18 - p. 1206-1212 , 2023
Link: https://doi.org/10.1093/..
 
?
14

Best practices for supporting and improving pharmacy reside..:

Murphy, John E. ; Azad, Aniqa ; Barreto, Jason N....
JACCP:JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.  7 (2023)  1 - p. 75-84 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Direct Oral Anticoagulants Versus Warfarin for Venous Throm..:

Tijani, Aminat ; Coons, Eric M. ; Mizuki, Britta...
Annals of Pharmacotherapy.  57 (2022)  7 - p. 787-794 , 2022
Link: https://doi.org/10.1177/..
 
1-15